3//SEC Filing
YUEN THOMAS C K 3
Accession 0001683168-21-004019
CIK 0001157075other
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 6:24 PM ET
Size
9.5 KB
Accession
0001683168-21-004019
Insider Transaction Report
Form 3
YUEN THOMAS C K
Director
Holdings
Stock Option (right to buy)
Exercise: $60.60From: 2019-05-01Exp: 2024-05-01→ Common Stock (334 underlying)Stock Option (right to buy)
Exercise: $26.55From: 2021-05-01Exp: 2026-05-01→ Common Stock (334 underlying)- 1,667
Common Stock
Stock Option (right to buy)
Exercise: $87.00From: 2017-07-03Exp: 2022-07-03→ Common Stock (334 underlying)Stock Option (right to buy)
Exercise: $36.00From: 2020-05-01Exp: 2025-05-01→ Common Stock (334 underlying)Stock Option (right to buy)
Exercise: $80.85From: 2018-05-01Exp: 2023-05-01→ Common Stock (334 underlying)
Footnotes (2)
- [F1]The number of shares has been adjusted to reflect a one-for-1,500 reverse stock split of the Issuer's common stock effected on July 12, 2021 (the "Reverse Split").
- [F2]The exercise price has been adjusted to reflect the Reverse Split.
Documents
Issuer
PharmaCyte Biotech, Inc.
CIK 0001157075
Entity typeother
IncorporatedCA
Related Parties
1- filerCIK 0000902630
Filing Metadata
- Form type
- 3
- Filed
- Aug 30, 8:00 PM ET
- Accepted
- Aug 31, 6:24 PM ET
- Size
- 9.5 KB